Loxo Oncology competitors

Loxo Oncology's competitors include NovaBay Pharmaceuticals, Chiasma, LGC Biosearch Technologies and CureVac
Add company...
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Chiasma
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
LGC Biosearch Technologies
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
CureVac
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
Founding Date
Founding Date
2013
Founding Date
2000
Founding Date
2001
Founding Date
1842
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Stamford, US HQ
South San Francisco, US
Locations
Emeryville, US HQ
Locations
Waltham, US HQ
Ness Ziona, IL
Locations
Teddington, GB HQ
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Employees
Employees
4757% increase
Employees
21
Employees
17
Employees
901
Employees
1843% increase
Valuation ($)
Valuation ($)
5.4 b
Valuation ($)
44.4 m
Valuation ($)
37.8 m
Valuation ($)
N/A
Valuation ($)
1.7 b
Facebook likes
Facebook likes
N/A
Facebook likes
4.3 k
Facebook likes
N/A
Facebook likes
1.1 k
Facebook likes
314
Twitter followers
Twitter followers
46
Twitter followers
2.2 k
Twitter followers
42
Twitter followers
2.4 k
Twitter followers
N/A

Financial

Net income
Net income
($72.4m) (FY, 2016)
Net income
N/A
Net income
($26.8m) (FY, 2017)
Net income
(£4.3m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 57m
Total funding raised
$ 13.6m
Total funding raised
$ 139.8m
Total funding raised
N/A
Total funding raised
$ 359m
For sources of this data, please see the company profileDownload Excel

View company profiles

NovaBay Pharmaceuticals
HQ
Emeryville, US
Employees
21

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

View company
Chiasma
HQ
Waltham, US
Employees
17

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.

View company
LGC Biosearch Technologies
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company
CureVac
HQ
Tübingen, DE
Employees
184↑ 3% increase

CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.

View company